(Q74180783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

D S Burgess

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J S Lewis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

872-878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Microbial etiology of acute pneumonia in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

The cost of treating community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980059-4

7 January 2021

10.1016/S0149-2918(00)80059-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10945513%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference